Effect of systemic alpha-2 adrenergic blockade on the morning increase in platelet aggregation in normal subjects

Muller, 1985, Circadian variation in the frequency of onset of acute myocardial infarction, N Engl J Med, 313, 1315, 10.1056/NEJM198511213132103 Willich, 1987, Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study Population, Am J Cardiol, 60, 801, 10.1016/0002-9149(87)91027-7 Willich, 1992, Increased onset of sudden cardiac death in the first three hours of awakening, Am J Cardiol, 70, 65, 10.1016/0002-9149(92)91391-G Tofler, 1987, Morning increase in platelet responsiveness to ADP and epinephrine, N Engl J Med, 316, 1514, 10.1056/NEJM198706113162405 Brezinski, 1988, Morning increase in platelet aggregability. Association with assumption of the upright posture, Circulation, 78, 35, 10.1161/01.CIR.78.1.35 Willich, 1989, Suppression of silent ischemia by metoprolol without alteration of the morning increase of platelet aggregability in patients with stable coronary artery disease, Circulation, 79, 557, 10.1161/01.CIR.79.3.557 Mittleman, 1993, Triggering of acute myocardial infarction by heavy physical exertion- protection against triggering by regular exertion, N Engl J Med, 329, 1677, 10.1056/NEJM199312023292301 Willich, 1993, Physical exertion as a trigger of acute myocardial infarction, N Engl J Med, 329, 1684, 10.1056/NEJM199312023292302 Wang, 1994, Different effects of strenuous exercise and moderate exercise on platelet function in men, Circulation, 90, 2877, 10.1161/01.CIR.90.6.2877 Kestin, 1993, Effect of strenuous exercise on platelet activation state and reactivity, Circulation, 88, 1502, 10.1161/01.CIR.88.4.1502 O’Brien, 1963, Some effects of adrenaline and anti-adrenaline compounds on platelets in vitro and in vivo, Nature, 200, 763, 10.1038/200763a0 Lanza, 1988, Epinephrine potentiates human platelet activation but is not an aggregating agent, Am J Physiol, 255, H1276 Hjemdahl, 1994, Epinephrine sensitizes human platelets in vivo and in vitro as studied by fibrinogen binding and P-selectin expression, Arterioscler Thromb, 14, 77, 10.1161/01.ATV.14.1.77 Larsson, 1992, Alpha-adrenoreceptor blockade by phentolamine inhibits adrenaline-induced activation in vivo without affecting resting measurements, Clin Sci, 82, 369, 10.1042/cs0820369 Larsson, 1992, Significance of platelet α adrenoceptors for platelet responses in vivo and in vitro, Thromb Haemost, 68, 687, 10.1055/s-0038-1646345 Ardlie, 1985, Effect on human platelets of catecholamines at levels achieved in the circulation, Atherosclerosis, 58, 251, 10.1016/0021-9150(85)90070-X Ardlie, 1984, Platelets activation by circulating levels of hormones, Thromb Res, 36, 315, 10.1016/0049-3848(84)90322-0 Diodati, 1992, Platelet activation across the coronary bed in patients with stable coronary artery disease, Circulation, 86, 1186, 10.1161/01.CIR.86.4.1186 Biaggoni, 1994, Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure, J Clin Pharmacol, 34, 418, 10.1002/j.1552-4604.1994.tb04981.x Eisenhofer, 1986, Simultaneous liquid chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma and their response to inhibition of monoamineoxidase, Clin Chem, 32, 2030, 10.1093/clinchem/32.11.2030 Guthrie, 1990, Yohimbine bioavailability in humans, Eur J Clin Pharmacol, 3, 409, 10.1007/BF00315421 Robertson, 1979, Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man, Circulation, 59, 637, 10.1161/01.CIR.59.4.637 Larsson, 1994, Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin, Circulation, 89, 1951, 10.1161/01.CIR.89.5.1951 Siess, 1982, Plasma catecholamines, platelet aggregation and associated thromboxane formation after physical exercise, smoking or norepinephrine infusion, Circulation, 66, 44, 10.1161/01.CIR.66.1.44 Reiss, 1986, Critical evaluation of platelet aggregation in whole human blood, Am J Clin Pathol, 85, 50, 10.1093/ajcp/85.1.50 Cardinal, 1980, The electronic aggregometer, J Pharmacol Meth, 3, 135, 10.1016/0160-5402(80)90024-8 Le Verge, 1992, Determination of yohimbine and its two hydroxylated metabolites in humans by high performance liquid chromatography and mass spectral analysis, J Chromatogr, 574, 283, 10.1016/0378-4347(92)80041-N Berlan, 1993, A2-adrenoceptor antagonist potencies of two hydroxylated metabolities of yohimbine, Br J Pharmacol, 108, 927, 10.1111/j.1476-5381.1993.tb13488.x